Metraipolis › archive › dc_32a6bc5ff6eb

Long-Term Outcomes in Hemodialysis Patients According to Combined NT-proBNP and Galectin-3 Biomarker Profiles — Europe PMC PMID:41682810

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41682810
DOI
10.3390/jcm15031129
License (as archived)
solo-consultazione
Archived
2026-11-06T08:31:12.867Z
SHA-256 of the archived text
de143318179af37d3c19cc7865ea0e2c9577aefb40ad81bb8536c7b539fc4ebd
Stable URL of this page
https://metraipolis.com/documento/dc_32a6bc5ff6eb

How to cite

Long-Term Outcomes in Hemodialysis Patients According to Combined NT-proBNP and Galectin-3 Biomarker Profiles — Europe PMC PMID:41682810 — Europe PMC (en), https://europepmc.org/article/MED/41682810 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_32a6bc5ff6eb (Metraipolis archive dc_32a6bc5ff6eb, sha256 de143318179af37d3c19cc7865ea0e2c9577aefb40ad81bb8536c7b539fc4ebd)
BibTeX
@misc{dc32a6bc5ff6eb,
  title = {Long-Term Outcomes in Hemodialysis Patients According to Combined NT-proBNP and Galectin-3 Biomarker Profiles — Europe PMC PMID:41682810},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41682810},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_32a6bc5ff6eb; sha256 de143318179af37d3c19cc7865ea0e2c9577aefb40ad81bb8536c7b539fc4ebd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41682810. Agents can read the archived copy with the MCP tool read_document.